Clinical Trials Logo

Clinical Trial Summary

This clinical trial is to evaluate the effectiveness and the safety of high intensity focused ultrasound (HIFU) in the treatment of benign thyroid nodules.


Clinical Trial Description

This clinical trial is a prospective, multicentre, randomized, controlled study of high intensity focused ultrasound (HIFU) treatment of benign thyroid nodules. this study will include 240 patients with benign thyroid nodules that meet all ths the inclusion / exclusion criteria and will be randomly divided into two groups at 1: 1 ratio. Patients in the test group will be treated with high intensity focused ultrasound (HIFU), while patients in the control group will be actively observed and followed up by ultrasound examination. The primary objective of this clinical trial is to evaluate the efficacy of the test device in the treatment of benign thyroid nodules, and the secondary objective is to evaluate the safety of the test device in the treatment of benign thyroid nodules and the improvement of symptoms assessed by VAS score. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04233398
Study type Interventional
Source Theraclion
Contact Yao Zhong, Master
Phone +860755-21659096
Email joanna.zhong@theraclion.com
Status Not yet recruiting
Phase N/A
Start date August 2024
Completion date November 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04410601 - Post-thyroidectomy Dysphagia: An International Multicentric CONSORT - Compatible RCT N/A
Not yet recruiting NCT05758038 - US-guided RFA vs MWA in the Treatment of Benign Thyroid Nodules
Not yet recruiting NCT04298684 - Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes Phase 4
Recruiting NCT04666103 - Function Integrity of Neck Anatomy in Thyroid Surgery N/A
Recruiting NCT06117085 - CellFX ® Percutaneous Electrode (PE) Treatment of Benign Thyroid Nodules N/A